Win Advisors, Inc Pfizer Inc Transaction History

Win Advisors, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $2,755 - $3,597	66 Added 8.21%	870 $44,000
Q3 2022 Oct 27, 2022	SELL	$43.76 - $53.42 $10,458 - $12,767	-239 Reduced 22.91%	804 $35,000
Q2 2022 Jul 18, 2022	BUY	$46.53 - $55.17 $22,334 - $26,481	480 Added 85.26%	1,043 $55,000
Q1 2022 May 13, 2022	BUY	$45.75 - $56.69 $25,757 - $31,916	563 New	563 $29,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Win Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Win Advisors, Inc with notifications on news.